Loss of MiR-664 Expression Enhances Cutaneous Malignant Melanoma Proliferation by Upregulating PLP2

Proteolipid protein 2 (PLP2) has been shown to be upregulated in several cancers, including breast cancer, hepatocellular carcinoma, osteosarcoma, and melanoma. PLP2 specifically binds to phosphatidylinositol 3 kinase to activate the protein kinase B pathway to enhance cell proliferation, adhesion,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Zhenhua, Jian, Sun, Peng, Xuebiao, Liu, Yimin, Wang, Jianyu, Zheng, Li, Ou, Chengshan, Wang, Yinghui, Zeng, Weixia, Zhou, Meijuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616445/
https://www.ncbi.nlm.nih.gov/pubmed/26287415
http://dx.doi.org/10.1097/MD.0000000000001327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616445/
https://www.ncbi.nlm.nih.gov/pubmed/26287415
http://dx.doi.org/10.1097/MD.0000000000001327

Ejemplares similares